Cott (PRM) Stock Price, News & Analysis

Company Overview

Big Pharma Split Corp is a closed ended equity mutual fund launched and managed by Harvest Portfolios Group Inc. It invests in the public equity markets across United States. The fund primarily invests in the Pharmaceutical sector. Big Pharma Split Corp was formed on September 15, 2017 and is domiciled in Canada.

Key Stats

• Today's Range: C$13.15 to C$13.15
• 50-Day Range: C$13.01 to C$13.56
• 52-Week Range: C$12.95 to C$14.97
• Volume: 546 shs
• Average Volume: 1,254 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Buy

PRM Stock Analysis - Frequently Asked Questions

How have PRM shares performed this year?

Cott's stock was trading at C$13.01 on January 1st, 2025. Since then, PRM shares have increased by 1.1% and is now trading at C$13.15.
View the best growth stocks for 2025 here.

How were Cott's earnings last quarter?

Cott Corp. (TSE:PRM) issued its quarterly earnings data on Thursday, November, 7th. The company reported $0.45 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.38 by $0.07.

How do I buy shares of Cott?

Shares of PRM stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.

Company Calendar

• Ex-Dividend for 11/21 Dividend: 11/05/2024
• Last Earnings: 11/07/2024
• Dividend Payable: 11/21/2024
• Today: 1/21/2025

Industry, Sector and Symbol

• Stock Exchange: TSE
• Sector: Financial Services
• Industry: Asset Management
• Sub-Industry: Chemicals
• Current Symbol: TSE:PRM
• CUSIP: N/A
• CIK: N/A
• Web: www.harvestportfolios.com
• Phone: (416) 649-4541
• Fax: N/A
• Employees: 240
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: N/A
• Beta: N/A